| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IGMS | Common Stock | Award | $15.1K | +3K | +1.53% | $5.02 | 199K | 15 May 2024 | Direct | F1 |
| transaction | IGMS | Common Stock | Sale | -$8.38K | -1.11K | -0.56% | $7.58 | 198K | 14 Jun 2024 | Direct | F2, F3 |
| holding | IGMS | Common Stock | 4.04K | 14 Jun 2024 | See footnote | F4 |
| Id | Content |
|---|---|
| F1 | The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| F3 | This transaction was executed in multiple trades at prices ranging from $7.26 to $7.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F4 | The shares are held directly by the Reporting Person's spouse. |